- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: March 2016
- Public Summary Document (PSD) March 2016 PBAC Meeting - PDF
- Public Summary Document (PSD) March 2016 PBAC Meeting - Word
Ibrutinib – March 2016
Ibrutinib: 140 mg capsules, 90, Imbruvica®
Last updated
15 July 2016